Vireo Growth (VREOF) EBT Margin (2020 - 2026)
Vireo Growth (VREOF) reported EBT Margin of 3.95% for Q1 2026, up 1564.0% on a YoY basis from 0.24% in Q1 2025, and up 65.69% sequentially from 11.53% in Q4 2025.
Vireo Growth (VREOF) EBT Margin (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of EBT Margin data on file, last reported at 3.95% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 1564.0% year-over-year to 3.95%; the trailing twelve-month figure through Mar 2026 stood at 11.21% (up 776.0% YoY), and the FY2025 full-year result was 14.85%, up 215.0% from the prior year.
- EBT Margin advanced to 3.95% in Q1 2026, from 11.53% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 0.91% in Q2 2024 to a low of 104.27% in Q1 2022.
- A 5-year average of 25.42% and a median of 19.59% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 6351 bps in 2022 and soared 6894 bps in 2023, its largest moves.
- Tracing VREOF's EBT Margin over 5 years: stood at 38.52% in 2022, then surged by 61 bps to 14.87% in 2023, then sank by 205 bps to 45.39% in 2024, then surged by 75 bps to 11.53% in 2025, then surged by 66 bps to 3.95% in 2026.
- Business Quant data shows VREOF's EBT Margin at 3.95% in Q1 2026, 11.53% in Q4 2025, and 14.13% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.95% |
| Dec 31, 2025 | -11.53% |
| Sep 30, 2025 | -14.13% |
| Jun 30, 2025 | -20.97% |
| Mar 31, 2025 | -19.59% |
| Dec 31, 2024 | -45.39% |
| Sep 30, 2024 | -10.10% |
| Jun 30, 2024 | -0.91% |
| Mar 31, 2024 | -11.49% |
| Dec 31, 2023 | -14.87% |
| Sep 30, 2023 | -7.09% |
| Jun 30, 2023 | -28.40% |
| Mar 31, 2023 | -35.33% |
| Dec 31, 2022 | -38.52% |
| Sep 30, 2022 | -41.28% |
| Jun 30, 2022 | -24.36% |
| Mar 31, 2022 | -104.27% |
| Dec 31, 2021 | -86.26% |
| Sep 30, 2021 | -47.20% |
| Jun 30, 2021 | -42.88% |